Safety and Tolerability of TWP-201 in Healthy Female Subjects

Summary

This study is a randomized, double-blind, placebo-controlled, single dose, escalation, phase I clinical trial to evaluate the safety and tolerability of recombinant human follicle stimulating hormone Fc fusion protein injection (TWP-201) in healthy female subjects. The objective of the trial is to evaluate the safety and tolerability of TWP-201 in healthy female subjects.

Timeline

Start

2021-05-17

Primary completion

2022-10-31

Completion

2022-12-31

Drugs

Indications